Improving Provider Counseling Interventions in HIV Practice
Recruitment status was Active, not recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Hypothesis: HIV clinicians trained to deliver brief counseling messages and receiving cues from a brief computer survey on risk behaviors of their patients can counsel have an impact on patient's risk behaviors.
| Condition | Intervention |
|---|---|
|
HIV Infections |
Behavioral: Stage based counseling |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Health Services Research |
- Disclosure of HIV status to sex partners; unprotected sexual encounters. [ Time Frame: 12 months ]
| Estimated Enrollment: | 425 |
| Study Start Date: | September 2003 |
| Estimated Study Completion Date: | October 2007 |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 1
Provider receives cue sheet to assist with counseling.
|
Behavioral: Stage based counseling |
|
No Intervention: 2
Provider does not receive cue sheet.
|
Detailed Description:
This is a randomized controlled study. The purpose of this study is to assess the impact of the cue sheet as an aid to targeted provider behavioral counseling. All enrolled participants are HIV+ adults seen for regular medical care at a site affiliated with the Johns Hopkins AIDS Service. After consenting, participants will take an audio-assisted computer interviews to collect patient risk assessment data. For participants randomized to the intervention arm, the printed output on risk behaviors is then given to the provider along with cues for staged-based counseling for use during the same visit. Participants in the control arm take the same computerized risk assessment but there are no printed cue sheets. Risk behaviors of all participants are assessed at entry, at 6 months, and at 12 months. The main outcome measure is change in HIV transmission behaviors at 12 months for those in the intervention arm compared to the control arm.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- HIV seropositive
- English speaking
Exclusion Criteria:
- Cannot give informed consent
Contacts and Locations| United States, Maryland | |
| Johns Hopkins University School of Medicine | |
| Baltimore, Maryland, United States, 21205 | |
| Principal Investigator: | Emily Erbelding, M.D. | Johns Hopkins University |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00538993 History of Changes |
| Other Study ID Numbers: | H97HA01144 |
| Study First Received: | October 1, 2007 |
| Last Updated: | October 1, 2007 |
| Health Authority: | United States: Federal Government |
Additional relevant MeSH terms:
|
HIV Infections Acquired Immunodeficiency Syndrome Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Slow Virus Diseases |
ClinicalTrials.gov processed this record on May 16, 2013